Innovation Pharmaceuticals Inc (IPIX)

[kfcyahoo]

They've run three products, B for OM, K for ovarian cancer, and P for psoriasis through clinical trials in the states. B is crrently front and center and voted most likely to succeed. K, after a 2 person ph 2 to has been declared a success-await next move. Regarding P, sounds like it's taking a nap (at best). P could have tripped up somewhere along the trial and now considered "Abby Normal".

Beware blazing saddles.

p.s ABBISSI UP was done in Italy wasn't it? Has fda/clinicaltrials been involved at all with it to date? Does it matter?